Literature DB >> 3379186

Pulmonary barotrauma including orbital emphysema following inhalation of toxic gas.

D Shulman1, D Reshef, R Nesher, Y Donchin, S Cotev.   

Abstract

Severe pulmonary barotrauma occurred following smoke and toxic gas inhalation in a 20-year-old male. He developed pneumothorax, pneumomediastinum, and extensive facial subcutaneous emphysema which intensified during treatment with positive pressure ventilation. Following the appearance of diplopia and exotropia, orbital emphysema was demonstrated radiologically. The diplopia and exotropia were manifestations of mechanical interference in extra-ocular muscle function by the intra-orbital air, an unusual expression of pulmonary barotrauma.

Entities:  

Mesh:

Year:  1988        PMID: 3379186     DOI: 10.1007/bf00717999

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  5 in total

1.  Pneumotomography of the orbit.

Authors:  T I BERTELSEN
Journal:  Arch Ophthalmol       Date:  1962-10

2.  Hypotension secondary to air trapping treated with expiratory flow retard.

Authors:  J T Weng; D E Smith; G B Graybar; R R Kirby
Journal:  Anesthesiology       Date:  1984-04       Impact factor: 7.892

3.  Early respiratory abnormalities from smoke inhalation.

Authors:  M Cahalane; R H Demling
Journal:  JAMA       Date:  1984-02-10       Impact factor: 56.272

4.  Spontaneous rupture of the esophagus presenting with unilateral proptosis.

Authors:  S M Schneider; D Goodman
Journal:  Ann Emerg Med       Date:  1984-05       Impact factor: 5.721

5.  Ptosis associated with iatrogenic pneumothorax: a false lateralizing sign.

Authors:  D Widder
Journal:  Arch Intern Med       Date:  1982-01
  5 in total
  1 in total

1.  Inhalation lung injury induced by smoke bombs in children: CT manifestations, dynamic evolution features and quantitative analysis.

Authors:  Yaqiong Ma; Shikui Zhang; Lianping Zhao; Xing Zhou; Zeqing Mao; Huaxin Xu; Xiaorui Ru; Gang Huang
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.